Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth

Published:2017-09-30 Issue:58 Volume:8 Page:98471-98481
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhu Hua¹²,Mao Jia-Hui³,Wang Yin⁴,Gu Dong-Hua²,Pan Xiao-Dong²,Shan Yuxi¹,Zheng Bing²

Affiliation:

1. The Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, China

2. The Department of Urology, The Second Affiliated Hospital of Nantong University, Nantong, China

3. Department of Pathophysiology, Nantong University School of Medicine, Nantong, China

4. Institute of Neuroscience, Soochow University, Suzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery;European Urology Oncology;2024-08

2. Targeting apoptosis in clear cell renal cell carcinoma;Biomedicine & Pharmacotherapy;2024-06

3. Essential role of bromodomain proteins in renal cell carcinoma (Review);Molecular Medicine Reports;2023-06-08

4. SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth;Cell Death & Disease;2021-07-20

5. Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer;Current Medicinal Chemistry;2021-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP